705 related articles for article (PubMed ID: 21052936)
1. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently.
Fu H; Dou J; Li W; Cui W; Mak S; Hu Q; Luo J; Lam CS; Pang Y; Youdim MB; Han Y
Eur J Pharmacol; 2009 Nov; 623(1-3):14-21. PubMed ID: 19765582
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.
Ortega A; Rincón Á; Jiménez-Aliaga KL; Bermejo-Bescós P; Martín-Aragón S; Molina MT; Csákÿ AG
Bioorg Med Chem Lett; 2011 Apr; 21(8):2183-7. PubMed ID: 21441028
[TBL] [Abstract][Full Text] [Related]
6. Secretase inhibitors and modulators for Alzheimer's disease treatment.
Tomita T
Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
[TBL] [Abstract][Full Text] [Related]
7. Secretases as therapeutic targets for Alzheimer's disease.
Woo HN; Baik SH; Park JS; Gwon AR; Yang S; Yun YK; Jo DG
Biochem Biophys Res Commun; 2011 Jan; 404(1):10-5. PubMed ID: 21130746
[TBL] [Abstract][Full Text] [Related]
8. Progress in Alzheimer's disease drug discovery: an update.
Williams M
Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
10. Efficient four-drug cocktail therapy targeting amyloid-β peptide for Alzheimer's disease.
Asai M; Iwata N; Tomita T; Iwatsubo T; Ishiura S; Saido TC; Maruyama K
J Neurosci Res; 2010 Dec; 88(16):3588-97. PubMed ID: 20890992
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease.
León R; Garcia AG; Marco-Contelles J
Med Res Rev; 2013 Jan; 33(1):139-89. PubMed ID: 21793014
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease pathogenesis and therapeutic interventions.
Parihar MS; Hemnani T
J Clin Neurosci; 2004 Jun; 11(5):456-67. PubMed ID: 15177383
[TBL] [Abstract][Full Text] [Related]
13. Advances in gamma-secretase modulation.
Pissarnitski D
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
16. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
17. Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.
Bolognesi ML; Bartolini M; Tarozzi A; Morroni F; Lizzi F; Milelli A; Minarini A; Rosini M; Hrelia P; Andrisano V; Melchiorre C
Bioorg Med Chem Lett; 2011 May; 21(9):2655-8. PubMed ID: 21236667
[TBL] [Abstract][Full Text] [Related]
18. [Gamma-secretase inhibitors in Alzheimer's disease therapy].
Katarína S; Jan K; Kamil K; Kamil M
Ceska Slov Farm; 2012 Jun; 61(3):93-100. PubMed ID: 22913824
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase.
Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J
Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488
[TBL] [Abstract][Full Text] [Related]
20. Effects of galantamine on β-amyloid release and beta-site cleaving enzyme 1 expression in differentiated human neuroblastoma SH-SY5Y cells.
Li Q; Wu D; Zhang L; Zhang Y
Exp Gerontol; 2010 Nov; 45(11):842-7. PubMed ID: 20600777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
